Related Experiment Video
Updated: Jun 9, 2025

Postoperative Ileus Murine Model
Published on: July 12, 2024
Postoperative ileus-Immune mechanisms and potential therapeutic interventions
Zheng Wang1, Nathalie Stakenborg1, Guy Boeckxstaens1
1Center of Intestinal Neuro-Immune Interactions, Translational Research Center for GI Disorders (TARGID), Department of Chronic Diseases, Metabolism and Ageing, KU Leuven-University of Leuven, Leuven, Belgium.
Postoperative ileus (POI) involves neurogenic and immune phases disrupting gut motility. Understanding these mechanisms, particularly macrophage activation, is key to developing new therapies for this common surgical complication.
Area of Science:
- Gastroenterology
- Surgical Pathology
- Immunology
Background:
- Postoperative ileus (POI) is a temporary cessation of gastrointestinal motility after abdominal surgery.
- POI involves an early neurogenic phase and a later immune-mediated phase characterized by sterile inflammation.
- Macrophage activation in the muscularis layer triggers inflammation, impairing the enteric nervous system (ENS) and motility.
Purpose of the Study:
- To review recent findings on the pathophysiological mechanisms of POI.
- To discuss emerging therapeutic strategies for managing POI.
Main Methods:
- Literature review of recent research on POI pathophysiology.
- Analysis of studies investigating neural and immune pathways in POI.
- Evaluation of potential therapeutic targets and strategies.
Main Results:
- Detailed description of the dual-phase mechanism of POI.
- Emphasis on the role of sterile inflammation and macrophage activation.
- Identification of key molecular and cellular players in ENS dysfunction.
Conclusions:
- Understanding the complex pathophysiology of POI is crucial for effective treatment.
- Targeting immune-mediated inflammation and ENS dysfunction offers promising therapeutic avenues.
- Further research into novel therapeutic strategies could alleviate POI burdens.
More Related Videos
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
08:07Author Spotlight: Isolation and Characterization of Equine Submucosal Enteric Glia — Implications for Preventing Postoperative Complications in Colic Surgery
Published on: October 4, 2024
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...